1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Neutralizing Antibodies
        1.2.3 Anti-inflammatory Drugs
    1.3 Market by Application
        1.3.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 COVID-19
        1.3.3 Influenza
        1.3.4 Malaria
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biologic Medication in COVID-19 Market Perspective (2017-2028)
    2.2 Biologic Medication in COVID-19 Growth Trends by Region
        2.2.1 Biologic Medication in COVID-19 Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biologic Medication in COVID-19 Historic Market Size by Region (2017-2022)
        2.2.3 Biologic Medication in COVID-19 Forecasted Market Size by Region (2023-2028)
    2.3 Biologic Medication in COVID-19 Market Dynamics
        2.3.1 Biologic Medication in COVID-19 Industry Trends
        2.3.2 Biologic Medication in COVID-19 Market Drivers
        2.3.3 Biologic Medication in COVID-19 Market Challenges
        2.3.4 Biologic Medication in COVID-19 Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biologic Medication in COVID-19 Players by Revenue
        3.1.1 Global Top Biologic Medication in COVID-19 Players by Revenue (2017-2022)
        3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2017-2022)
    3.2 Global Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
    3.4 Global Biologic Medication in COVID-19 Market Concentration Ratio
        3.4.1 Global Biologic Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biologic Medication in COVID-19 Revenue in 2021
    3.5 Biologic Medication in COVID-19 Key Players Head office and Area Served
    3.6 Key Players Biologic Medication in COVID-19 Product Solution and Service
    3.7 Date of Enter into Biologic Medication in COVID-19 Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Medication in COVID-19 Breakdown Data by Type
    4.1 Global Biologic Medication in COVID-19 Historic Market Size by Type (2017-2022)
    4.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2023-2028)
5 Biologic Medication in COVID-19 Breakdown Data by Application
    5.1 Global Biologic Medication in COVID-19 Historic Market Size by Application (2017-2022)
    5.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biologic Medication in COVID-19 Market Size (2017-2028)
    6.2 North America Biologic Medication in COVID-19 Market Size by Type
        6.2.1 North America Biologic Medication in COVID-19 Market Size by Type (2017-2022)
        6.2.2 North America Biologic Medication in COVID-19 Market Size by Type (2023-2028)
        6.2.3 North America Biologic Medication in COVID-19 Market Share by Type (2017-2028)
    6.3 North America Biologic Medication in COVID-19 Market Size by Application
        6.3.1 North America Biologic Medication in COVID-19 Market Size by Application (2017-2022)
        6.3.2 North America Biologic Medication in COVID-19 Market Size by Application (2023-2028)
        6.3.3 North America Biologic Medication in COVID-19 Market Share by Application (2017-2028)
    6.4 North America Biologic Medication in COVID-19 Market Size by Country
        6.4.1 North America Biologic Medication in COVID-19 Market Size by Country (2017-2022)
        6.4.2 North America Biologic Medication in COVID-19 Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Biologic Medication in COVID-19 Market Size (2017-2028)
    7.2 Europe Biologic Medication in COVID-19 Market Size by Type
        7.2.1 Europe Biologic Medication in COVID-19 Market Size by Type (2017-2022)
        7.2.2 Europe Biologic Medication in COVID-19 Market Size by Type (2023-2028)
        7.2.3 Europe Biologic Medication in COVID-19 Market Share by Type (2017-2028)
    7.3 Europe Biologic Medication in COVID-19 Market Size by Application
        7.3.1 Europe Biologic Medication in COVID-19 Market Size by Application (2017-2022)
        7.3.2 Europe Biologic Medication in COVID-19 Market Size by Application (2023-2028)
        7.3.3 Europe Biologic Medication in COVID-19 Market Share by Application (2017-2028)
    7.4 Europe Biologic Medication in COVID-19 Market Size by Country
        7.4.1 Europe Biologic Medication in COVID-19 Market Size by Country (2017-2022)
        7.4.2 Europe Biologic Medication in COVID-19 Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biologic Medication in COVID-19 Market Size (2017-2028)
    8.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type
        8.2.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Biologic Medication in COVID-19 Market Share by Type (2017-2028)
    8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application
        8.3.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Biologic Medication in COVID-19 Market Share by Application (2017-2028)
    8.4 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region
        8.4.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Biologic Medication in COVID-19 Market Size (2017-2028)
    9.2 Latin America Biologic Medication in COVID-19 Market Size by Type
        9.2.1 Latin America Biologic Medication in COVID-19 Market Size by Type (2017-2022)
        9.2.2 Latin America Biologic Medication in COVID-19 Market Size by Type (2023-2028)
        9.2.3 Latin America Biologic Medication in COVID-19 Market Share by Type (2017-2028)
    9.3 Latin America Biologic Medication in COVID-19 Market Size by Application
        9.3.1 Latin America Biologic Medication in COVID-19 Market Size by Application (2017-2022)
        9.3.2 Latin America Biologic Medication in COVID-19 Market Size by Application (2023-2028)
        9.3.3 Latin America Biologic Medication in COVID-19 Market Share by Application (2017-2028)
    9.4 Latin America Biologic Medication in COVID-19 Market Size by Country
        9.4.1 Latin America Biologic Medication in COVID-19 Market Size by Country (2017-2022)
        9.4.2 Latin America Biologic Medication in COVID-19 Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biologic Medication in COVID-19 Market Size (2017-2028)
    10.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type
        10.2.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Biologic Medication in COVID-19 Market Share by Type (2017-2028)
    10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application
        10.3.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Biologic Medication in COVID-19 Market Share by Application (2017-2028)
    10.4 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country
        10.4.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Biologic Medication in COVID-19 Introduction
        11.1.4 Roche Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Biologic Medication in COVID-19 Introduction
        11.2.4 Sanofi Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.2.5 Sanofi Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Biologic Medication in COVID-19 Introduction
        11.3.4 Novartis Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Merck Business Overview
        11.4.3 Merck Biologic Medication in COVID-19 Introduction
        11.4.4 Merck Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.4.5 Merck Recent Developments
    11.5 Bayer
        11.5.1 Bayer Company Details
        11.5.2 Bayer Business Overview
        11.5.3 Bayer Biologic Medication in COVID-19 Introduction
        11.5.4 Bayer Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.5.5 Bayer Recent Developments
    11.6 Shutaishen
        11.6.1 Shutaishen Company Details
        11.6.2 Shutaishen Business Overview
        11.6.3 Shutaishen Biologic Medication in COVID-19 Introduction
        11.6.4 Shutaishen Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.6.5 Shutaishen Recent Developments
    11.7 Biogen
        11.7.1 Biogen Company Details
        11.7.2 Biogen Business Overview
        11.7.3 Biogen Biologic Medication in COVID-19 Introduction
        11.7.4 Biogen Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.7.5 Biogen Recent Developments
    11.8 Regeneron Pharmaceuticals
        11.8.1 Regeneron Pharmaceuticals Company Details
        11.8.2 Regeneron Pharmaceuticals Business Overview
        11.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Introduction
        11.8.4 Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.8.5 Regeneron Pharmaceuticals Recent Developments
    11.9 Vir Biotech
        11.9.1 Vir Biotech Company Details
        11.9.2 Vir Biotech Business Overview
        11.9.3 Vir Biotech Biologic Medication in COVID-19 Introduction
        11.9.4 Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.9.5 Vir Biotech Recent Developments
    11.10 Junshi Biosciences
        11.10.1 Junshi Biosciences Company Details
        11.10.2 Junshi Biosciences Business Overview
        11.10.3 Junshi Biosciences Biologic Medication in COVID-19 Introduction
        11.10.4 Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.10.5 Junshi Biosciences Recent Developments
    11.11 Anke Biotechnology
        11.11.1 Anke Biotechnology Company Details
        11.11.2 Anke Biotechnology Business Overview
        11.11.3 Anke Biotechnology Biologic Medication in COVID-19 Introduction
        11.11.4 Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.11.5 Anke Biotechnology Recent Developments
    11.12 OncoImmune
        11.12.1 OncoImmune Company Details
        11.12.2 OncoImmune Business Overview
        11.12.3 OncoImmune Biologic Medication in COVID-19 Introduction
        11.12.4 OncoImmune Revenue in Biologic Medication in COVID-19 Business (2017-2022)
        11.12.5 OncoImmune Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Biologic Medication in COVID-19 Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Neutralizing Antibodies
    Table 3. Key Players of Anti-inflammatory Drugs
    Table 4. Global Biologic Medication in COVID-19 Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Biologic Medication in COVID-19 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Biologic Medication in COVID-19 Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Biologic Medication in COVID-19 Market Share by Region (2017-2022)
    Table 8. Global Biologic Medication in COVID-19 Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Biologic Medication in COVID-19 Market Share by Region (2023-2028)
    Table 10. Biologic Medication in COVID-19 Market Trends
    Table 11. Biologic Medication in COVID-19 Market Drivers
    Table 12. Biologic Medication in COVID-19 Market Challenges
    Table 13. Biologic Medication in COVID-19 Market Restraints
    Table 14. Global Biologic Medication in COVID-19 Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Biologic Medication in COVID-19 Revenue Share by Players (2017-2022)
    Table 16. Global Top Biologic Medication in COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medication in COVID-19 as of 2021)
    Table 17. Ranking of Global Top Biologic Medication in COVID-19 Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Biologic Medication in COVID-19 Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Biologic Medication in COVID-19 Product Solution and Service
    Table 21. Date of Enter into Biologic Medication in COVID-19 Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2017-2022)
    Table 25. Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2023-2028)
    Table 27. Global Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Biologic Medication in COVID-19 Revenue Share by Application (2017-2022)
    Table 29. Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Biologic Medication in COVID-19 Revenue Share by Application (2023-2028)
    Table 31. North America Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Biologic Medication in COVID-19 Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Biologic Medication in COVID-19 Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Biologic Medication in COVID-19 Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Biologic Medication in COVID-19 Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Biologic Medication in COVID-19 Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Biologic Medication in COVID-19 Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Biologic Medication in COVID-19 Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Biologic Medication in COVID-19 Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Biologic Medication in COVID-19 Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Biologic Medication in COVID-19 Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Roche Company Details
    Table 62. Roche Business Overview
    Table 63. Roche Biologic Medication in COVID-19 Product
    Table 64. Roche Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 65. Roche Recent Developments
    Table 66. Sanofi Company Details
    Table 67. Sanofi Business Overview
    Table 68. Sanofi Biologic Medication in COVID-19 Product
    Table 69. Sanofi Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 70. Sanofi Recent Developments
    Table 71. Novartis Company Details
    Table 72. Novartis Business Overview
    Table 73. Novartis Biologic Medication in COVID-19 Product
    Table 74. Novartis Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 75. Novartis Recent Developments
    Table 76. Merck Company Details
    Table 77. Merck Business Overview
    Table 78. Merck Biologic Medication in COVID-19 Product
    Table 79. Merck Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 80. Merck Recent Developments
    Table 81. Bayer Company Details
    Table 82. Bayer Business Overview
    Table 83. Bayer Biologic Medication in COVID-19 Product
    Table 84. Bayer Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 85. Bayer Recent Developments
    Table 86. Shutaishen Company Details
    Table 87. Shutaishen Business Overview
    Table 88. Shutaishen Biologic Medication in COVID-19 Product
    Table 89. Shutaishen Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 90. Shutaishen Recent Developments
    Table 91. Biogen Company Details
    Table 92. Biogen Business Overview
    Table 93. Biogen Biologic Medication in COVID-19 Product
    Table 94. Biogen Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 95. Biogen Recent Developments
    Table 96. Regeneron Pharmaceuticals Company Details
    Table 97. Regeneron Pharmaceuticals Business Overview
    Table 98. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product
    Table 99. Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 100. Regeneron Pharmaceuticals Recent Developments
    Table 101. Vir Biotech Company Details
    Table 102. Vir Biotech Business Overview
    Table 103. Vir Biotech Biologic Medication in COVID-19 Product
    Table 104. Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 105. Vir Biotech Recent Developments
    Table 106. Junshi Biosciences Company Details
    Table 107. Junshi Biosciences Business Overview
    Table 108. Junshi Biosciences Biologic Medication in COVID-19 Product
    Table 109. Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 110. Junshi Biosciences Recent Developments
    Table 111. Anke Biotechnology Company Details
    Table 112. Anke Biotechnology Business Overview
    Table 113. Anke Biotechnology Biologic Medication in COVID-19 Product
    Table 114. Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 115. Anke Biotechnology Recent Developments
    Table 116. OncoImmune Company Details
    Table 117. OncoImmune Business Overview
    Table 118. OncoImmune Biologic Medication in COVID-19 Product
    Table 119. OncoImmune Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
    Table 120. OncoImmune Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biologic Medication in COVID-19 Market Share by Type: 2021 VS 2028
    Figure 2. Neutralizing Antibodies Features
    Figure 3. Anti-inflammatory Drugs Features
    Figure 4. Global Biologic Medication in COVID-19 Market Share by Application: 2021 VS 2028
    Figure 5. COVID-19 Case Studies
    Figure 6. Influenza Case Studies
    Figure 7. Malaria Case Studies
    Figure 8. Others Case Studies
    Figure 9. Biologic Medication in COVID-19 Report Years Considered
    Figure 10. Global Biologic Medication in COVID-19 Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Biologic Medication in COVID-19 Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Biologic Medication in COVID-19 Market Share by Region: 2021 VS 2028
    Figure 13. Global Biologic Medication in COVID-19 Market Share by Players in 2021
    Figure 14. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medication in COVID-19 as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Biologic Medication in COVID-19 Revenue in 2021
    Figure 16. North America Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
    Figure 18. North America Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
    Figure 19. North America Biologic Medication in COVID-19 Market Size Share by Country (2017-2028)
    Figure 20. United States Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Biologic Medication in COVID-19 Market Size Share by Country (2017-2028)
    Figure 26. Germany Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Biologic Medication in COVID-19 Market Size Share by Region (2017-2028)
    Figure 36. China Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Biologic Medication in COVID-19 Market Size Share by Country (2017-2028)
    Figure 46. Mexico Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Biologic Medication in COVID-19 Market Size Share by Country (2017-2028)
    Figure 52. Turkey Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Roche Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 58. Merck Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 59. Bayer Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 60. Shutaishen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 61. Biogen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 62. Regeneron Pharmaceuticals Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 63. Vir Biotech Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 64. Junshi Biosciences Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 65. Anke Biotechnology Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 66. OncoImmune Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed